XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock Outstanding [Member]
Common Stock Including Additional Paid in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock, Common [Member]
Total
Balance (in shares) at Dec. 31, 2021     5,645,687          
Balance at Dec. 31, 2021       $ 114,108 $ 97,442 $ 179   $ 211,729
Net income         15,187     15,187
Other comprehensive income (loss)           (61,099)   (61,099)
Issuance of common stock through Employee Stock Purchase Plan (in shares)     4,891          
Issuance of common stock through Employee Stock Purchase Plan       252       252
Forfeited restricted dividend reinvestment shares (in shares)     (48)          
Forfeited restricted dividend reinvestment shares       $ 0 0
Issuance of common stock from vested restricted share grants through stock compensation plans (in shares)     11,541          
Issuance of common stock from vested restricted share grants through stock compensation plans       0       0
Stock-based compensation expense       719       719
Common stock repurchased (in shares)     (10,294)          
Common stock repurchased       (388) (388)
Cash dividends declared         (3,781)     (3,781)
Balance (in shares) at Jun. 30, 2022     5,651,777          
Balance at Jun. 30, 2022       115,079 108,848 (60,920)   162,619
Balance (in shares) at Mar. 31, 2022     5,659,068          
Balance at Mar. 31, 2022       114,666 103,074 (42,497)   175,243
Net income         7,664     7,664
Other comprehensive income (loss)           (18,423)   (18,423)
Forfeited restricted dividend reinvestment shares (in shares)     (48)          
Forfeited restricted dividend reinvestment shares       0 0
Issuance of common stock from vested restricted share grants through stock compensation plans (in shares)     3,051          
Issuance of common stock from vested restricted share grants through stock compensation plans       0       0
Stock-based compensation expense       413       413
Common stock repurchased (in shares)     (10,294)          
Common stock repurchased       0 (388) (388)
Cash dividends declared         (1,890)     (1,890)
Balance (in shares) at Jun. 30, 2022     5,651,777          
Balance at Jun. 30, 2022       115,079 108,848 (60,920)   162,619
Balance (in shares) at Dec. 31, 2022     5,630,794          
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022 $ (1,326) $ (1,326)            
Balance at Dec. 31, 2022       115,611 119,754 (71,152) (1,263) 162,950
Net income         12,402     12,402
Other comprehensive income (loss)           5,884   5,884
Issuance of common stock through Employee Stock Purchase Plan (in shares)     7,294          
Issuance of common stock through Employee Stock Purchase Plan       302       302
Issuance of common stock from vested restricted share grants through stock compensation plans (in shares)     24,283          
Issuance of common stock from vested restricted share grants through stock compensation plans       0        
Stock-based compensation expense       963       $ 963
Common stock repurchased (in shares)               (32,554)
Cash dividends declared         (4,119)     $ (4,119)
Re-issuance of common stock through Dividend Reinvestment Plan (in shares)     17,576          
Re-issuance of common stock through Dividend Reinvestment Plan       135     673 808
Issuance of common stock through exercise of SSARs (in shares)     2,699          
Issuance of common stock through exercise of SSARs       0 0
Repurchase of shares to cover withholdings (in shares)     (1,386)          
Repurchase of shares to cover withholdings             (68) (120)
Balance (in shares) at Jun. 30, 2023     5,681,260          
Balance at Jun. 30, 2023       116,959 126,711 (65,268) (658) 177,744
Balance (in shares) at Mar. 31, 2023     5,665,255          
Balance at Mar. 31, 2023       116,437 123,416 (62,938) (1,028) 175,887
Net income         5,362     5,362
Other comprehensive income (loss)       (2,330) (2,330)
Issuance of common stock from vested restricted share grants through stock compensation plans (in shares)     3,834          
Issuance of common stock from vested restricted share grants through stock compensation plans       0        
Stock-based compensation expense       518       518
Cash dividends declared         (2,067)     (2,067)
Re-issuance of common stock through Dividend Reinvestment Plan (in shares)     9,472          
Re-issuance of common stock through Dividend Reinvestment Plan       56     370 426
Issuance of common stock through exercise of SSARs (in shares)     2,699          
Issuance of common stock through exercise of SSARs       0 0
Repurchase of shares to cover withholdings (in shares)     0          
Repurchase of shares to cover withholdings             (52)
Balance (in shares) at Jun. 30, 2023     5,681,260          
Balance at Jun. 30, 2023       $ 116,959 $ 126,711 $ (65,268) $ (658) $ 177,744